The Global Ophthalmic
Viscoelastic Devices Market, by Product Type (Dispersive Ophthalmic
Viscoelastic Devices, and Cohesive Ophthalmic Viscoelastic Devices), by
Application (Cataract Surgery, Glaucoma Surgery, Vitreoretinal Surgery, Corneal
Transplantation Surgery, and Others), by Composition (Sodium Hyaluronate, Chondroitin
Sulfate, and Hydroxypropyl Methylcellulose), by End User (Ophthalmic Clinics,
Hospitals, and Academic and Research Institutes), and by Region (North America,
Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at
US$ 810.9 million in 2018, and is projected to exhibit a CAGR of 9.4%, during
the forecast period (2019-2027), as highlighted in a new report published by.
Increasing number of regulatory
approvals for ophthalmic viscoelastic devices is expected to propel growth of
the global ophthalmic viscoelastic devices market. For instance, in October
2015, Alcon, a division of Novartis focused on eye care, received U.S. Food and
Drug Administration approval for its AcrySof IQ Aspheric IOL with the UltraSert
Pre-loaded Delivery System for patients undergoing cataract surgery. Moreover,
in June 2015, the company received the CE marking for its AcrySof IQ Aspheric
IOL with the UltraSert Pre-loaded Delivery System.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2521
Browse 48 Market Data Tables and
32 Figures spread through 209 Pages and in-depth TOC on 'Ophthalmic
Viscoelastic Devices Market, by Product Type (Dispersive Ophthalmic
Viscoelastic Devices, and Cohesive Ophthalmic Viscoelastic Devices), by
Application (Cataract Surgery, Glaucoma Surgery, Vitreoretinal Surgery, Corneal
Transplantation Surgery, and Others), by Composition (Sodium Hyaluronate,
Chondroitin Sulfate, and Hydroxypropyl Methylcellulose), by End User
(Ophthalmic Clinics, Hospitals, and Academic and Research Institutes), and by
Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa) - Global Forecast to 2027' To know the latest trends and insights
related to Ophthalmic Viscoelastic Devices Market.
Increasing adoption of inorganic
strategies such as acquisitions by key players operating in the-eye care
industry is expected to drive growth of the ophthalmic viscoelastic devices
market. For instance, in July 2017, Rayner Surgical Group acquired the
ophthalmic cataract surgery business of Aptissen SA (Geneva, Switzerland).
Under this agreement, Rayner acquired the ophthalmic viscoelastic device
product portfolio including Ophteis, OphteisMax, OphteisBio, and Methylvisc.
This has helped Rayner to expand its presence in the global market by offering
these devices to customers all over the world. Moreover, product launches by
major key players is expected to boost growth of the ophthalmic viscoelastic
devices market in the near future. For instance, in July 2018, Amring
Pharmaceuticals Inc. launched its Biolon OVD (Ophthalmic Viscosurgical Device)
in the U.S. market. Biolon OVD is a fermentation-based, sterile, optically
clear, 1% (10mg/mL), sodium hyaluronate viscoelastic solution in sterile
prefilled syringes. These factors are expected to contribute to the significant
growth of the ophthalmic viscoelastic devices market over the forecast period.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/ophthalmic-viscoelastic-devices-market-2521
Key Takeaways of the Global
Ophthalmic Viscoelastic Devices Market:
The global ophthalmic
viscoelastic devices market is expected to expand at a CAGR of 9.4% during the
forecast period (2019–2027), owing to increasing initiatives by major players
such as development of innovative ophthalmic viscoelastic devices for
application in various ophthalmic surgeries. For instance, in February 2019,
Sight Sciences, Inc. initiated a clinical trial study to evaluate safety and
efficacy of the OMNI Surgical System for multiple micro-invasive glaucoma
surgery (MIGS) procedures. The study is estimated to complete in December 2020.
Furthermore, increasing
regulatory approvals of ophthalmic viscoelastic devices is contributing to
market growth. For instance, in April 2018, Sight Sciences received U.S. FDA
510(k) clearance for its OMNI Surgical System. The devices is indicated for
delivery of controlled volumes of viscoelastic fluid, as well as cutting of
trabecular meshwork tissue.
Major players operating in the
global ophthalmic viscoelastic devices market include Johnson & Johnson,
Rumex International Co., Bausch & Lomb Incorporated., Ophtechnics
Unlimited, Truviz Ophthalmic., Beye, LLC, Carl Zeiss Meditec AG, Precision
Lens, Iso Clear (Pty) Ltd., and Neu Micromed International Pvt. Ltd.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2521
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment